Skip to main content
. 2020 May 7;10:7714. doi: 10.1038/s41598-020-64880-x

Figure 1.

Figure 1

Vitamin K2 promotes glycolysis and inhibits TCA cycle in bladder cancer cells. (A–D) Vitamin K2 time or dose-dependently affected the glucose consumption and lactate production in bladder cancer T24 and EJ cells. (E) and (F) Western blot showed the effect of 50 μM Vitamin K2 on the expression of glycolytic proteins or enzymes in bladder cancer T24 and EJ cells. (G) T24 cells were exposed to 50 μM Vitamin K2 for 12 hours and the quantitative analysis of Acetyl-CoA amount was measured by LC-MS. (H) Western blot showed the effect of 50 μM Vitamin K2 on the phosphorylation of PDH in T24 cells. (I) and (J) T24 cells were exposed to 50 μM Vitamin K2 for 12 hours and the quantitative analysis of the metabolites content in TCA cycle was measured by LC-MS. Data are presented as the mean ± SD of at least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001.